1. Swept-source optical coherence tomography imaging of the cortical vitreous and the vitreoretinal interface in proliferative diabetic retinopathy: assessment of vitreoschisis, neovascularisation and the internal limiting membrane. 
    Muqit MM, Stanga PE.
    BR J Ophthalmol, 2004 Jul: 98(7):994-7. doi: 10.1136/bjophthalmol-2013-304452.
    Epub 2014 Mar 21. PubMed PMID: 24659354.
  2. The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients. 
    Vaidya A, Borgonovi E, Taylor RS, Sahel JA, Rizzo S, Stanga PE, Kukreja A, Walter P.
    BMC Ophthalmol. 2014 April 14;14:49. doi:10.1186/1471-2415-14-49.
    PubMed PMID: 24731533; PubMed Central PMCID: PM 3990272.
  3. BRC Support. Swept-source optical coherence tomography imaging in conservative and surgical management of premacular haemorrhages showing inflammatory response. 
    Tanawade RG, Muqit MM, McLeod D, Stanga PE.
    Clin Experiment Ophthalmol. 2015 Jan:43(1):77-79. doi:10.1111/ceo.12368.
    Epub 2014 Aug13. PubMed PMID: 24902611.
  4. BRC Support. In vivo imaging of cortical vitreous using 1050-nm swept-source deep range imaging optical coherence tomography. 
    Stanga PE, Sala-Puigdollers A, Caputo S, Jaberansari H, Cien M, Gray J, D’Souza Y, Charles SJ, Biswas S, Henson DB, McLeod D.
    Am J Ophthalmol. 2014 Feb;157(2):397-404.e2. doi: 10.1016/j.ajo.2013.10.008.
    Epub 2013 Oct 22.
  5. BRC Support. Fourier-domain optical coherence tomography evaluation of retinal and optic nerve head neovascularisation in proliferative diabetic retinopathy. 
    Muqit MM, Stanga PE.
    Br J Ophthalmol. 2014 Jan;98(1):65-72. doi: 10.1136/bjophthalmol-2013-303941.
    Epub 2013 Oct 24.
  6. BRC Support. Spatial changes of central field loss in diabetic retinopathy after laser. 
    Wang Y, Muqit MM, Stanga PE, Young LB, Henson DB.
    Optom Vis Sci. 2014 Jan;91(1):111-20. doi: 10.1097/OPX.0000000000000103.
  7. BRC Support. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy. 
    Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE.
    Acta Ophthalmol. 2013 May;91(3):251-8. doi: 10.1111/j.1755-3768.2011.02307.x.
    Epub 2011 Dec 16.
  8. BRC Support. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. 
    da Cruz L, Coley BF, Dorn J, Merlini F, Filley E, Christopher P, Chen FK,Wuyyuru V, Sahel J,Stanga P, Humayun M, Greenberg RJ, Dagnelie G; Argus II Study Group.
    Br J Ophthalmol. 2013 May;97(5):632-6. doi: 10.1136/bjophthalmol-2012-301525.
    Epub 2013 Feb 20.
  9. BRC Support. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. 
    Muqit MM, Young LB, McKenzie R, John B, Marcellino GR, Henson DB, Turner GS, Stanga PE.
    Br J Ophthalmol. 2013 Feb;97(2):220-7. doi: 10.1136/bjophthalmol-2012-302189.
    Epub 2012 Nov 24.
  10. BRC Support. The Royal College of Ophthalmologists’ clinical guidelines for diabetic retinopathy: a summary. 
    Ghanchi F;
    Diabetic Retinopathy Guidelines Working Group. Eye (Lond). 2013 Feb;27(2):285-7. doi: 10.1038/eye.2012.287.
    Epub 2013 Jan 11. No abstract available.
  11. BRC Support. Intravitreal injections: a healthcare failure modes and effects analysis. 
    Lanzetta P, Holz F, Monés J, Querques G, Stanga P, Veritti D, Barbone F, Brusaferro S, Isola M.
    Ophthalmologica. 2013;230(3):151-64. doi: 10.1159/000354549.
    Epub 2013 Aug 31.
  12. BRC Support. Use of the Argus II retinal prosthesis to improve visual guidance of fine hand movements. 
    Barry MP, Dagnelie G; Argus II Study Group.
    Invest Ophthalmol Vis Sci. 2012 Aug 1;53(9):5095-101. doi: 10.1167/iovs.12-9536.
  13. BRC Support. Microstructural changes following Inadvertent multi-spot laser photocoagulation of the fovea. 
    Stanga PE, Muqit MM, Marcellino GR.
    Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):945-7. doi: 10.1007/s00417-011-1719-4.
    Epub 2011 Jun 10. No abstract available.
  14. BRC Support. Interim results from the international trial of Second Sight’s visual prosthesis. 
    Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Sahel JA, Stanga PE, Cideciyan AV, Duncan JL, Eliott D, Filley E, Ho AC, Santos A, Safran AB, Arditi A, Del Priore LV, Greenberg RJ; Argus II Study Group.
    Ophthalmology. 2012 Apr;119(4):779-88. doi: 10.1016/j.ophtha.2011.09.028.
    Epub 2012 Jan 11.
  15. BRC Support. Study of clinical applications and safety for Pascal® laser photocoagulation in retinal vascular disorders. 
    Muqit MM, Sanghvi C, McLauchlan R, Delgado C, Young LB, Charles SJ, Marcellino GR, Stanga PE.
    Acta Ophthalmol. 2012 Mar;90(2):155-61. doi: 10.1111/j.1755-3768.2009.01854.x.
    Epub 2010 Feb 16.
  16. BRC Support. Presumed entecavir-induced ocular toxicity. 
    Muqit MK, Stanga PE, Vilar FJ, Patton N.
    Eye (Lond). 2011 Dec;25(12):1665-8. doi: 10.1038/eye.2011.259. Epub 2011 Oct 21.
    No abstract available.
  17. BRC Support. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4. 
    Muqit MM, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE.
    Eye (Lond). 2011 Nov;25(11):1447-56. doi: 10.1038/eye.2011.188.
    Epub 2011 Aug 5.
  18. BRC Support. Randomized clinical trial to evaluate the effects of Pascal panretinal photocoagulation on macular nerve fiber layer: Manchester Pascal Study report 3. 
    Muqit MM, Marcellino GR, Henson DB, Fenerty CH, Stanga PE.
    Retina. 2011 Sep;31(8):1699-707. doi: 10.1097/IAE.0b013e318207d188.
  19. BRC Support. Argus II Study Group. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. 
    Ahuja AK, Dorn JD, Caspi A, McMahon MJ, Dagnelie G, Dacruz L, Stanga P, Humayun MS, Greenberg RJ;
    Br J Ophthalmol. 2011 Apr;95(4):539-43. doi: 10.1136/bjo.2010.179622.
    Epub 2010 Sep 29.
  20. BRC Support. Spatial and spectral imaging of retinal laser photocoagulation burns. 
    Muqit MM, Denniss J, Nourrit V, Marcellino GR, Henson DB, Schiessl I, Stanga PE.
    Invest Ophthalmol Vis Sci. 2011 Feb 23;52(2):994-1002. doi: 10.1167/iovs.10-6309.
  21. BRC Support. High-resolution hyperspectral imaging of the retina with a modified fundus camera. 
    Nourrit V, Denniss J, Muqit MM, Schiessl I, Fenerty C, Stanga PE, Henson DB.
    J Fr Ophtalmol. 2010 Dec;33(10):686-92. doi: 10.1016/j.jfo.2010.10.010.
    Epub 2010 Nov 19.
  22. BRC Support. Fourier-Domain Optical Coherence Tomography Imaging of Gas Tamponade Following Macular Hole Surgery. 
    MMK Muqit, I Akram, GS Turner, PE Stanga.
    Ophthalmic Surg Lasers Imaging. 2010 Dec 1;41 Online:e1-6. doi: 10.3928/15428877-20101124-16.
  23. BRC Support. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. 
    PE Stanga, MMK Muqit.
    Retina. 2010 Nov-Dec;30(10):1749-50; author reply 1750-1.
  24. BRC Support. Laser Tissue Interactions. 
    MMK. Muqit, GR Marcellino, DB. Henson, LB Young, N Patton, SJ Charles, GS Turner, PE Stanga.
    Ophthalmology. 2010 Oct;117(10):2039, 2039.e1.
  25. BRC Support. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. 
    Ahuja AK, Dorn JD, Caspi A, McMahon MJ, Dagnelie G, Dacruz L, Stanga P, Humayun MS, Greenberg RJ; Argus II Study Group.
    Br J Ophthalmol. 2010 Sep 29. [Epub ahead of print]
  26. BRC Support. Spatial and Spectral Imaging of Retinal Laser Photocoagulation Burns. 
    MMK Muqit, J Denniss, V Nouritt, DB Henson, I Schiessel, PE Stanga.
    Invest Ophthalmol Vis Sci. 2010 Sep 22. [Epub ahead of print]
  27. BRC Support. Nidek MP-1 microperimetry and Fourier domain optical coherence tomography (FD-OCT) in X linked retinoschisis. 
    Biswas S, Funnell CL, Gray J, Bunting R, Lloyd IC, Stanga PE.
    Br J Ophthalmol. 2010 Jul;94(7):949-50.
  28. BRC Support Pain Responses of Pascal® 20 ms Multi-spot and 100 ms Single-spot Panretinal Photocoagulation: MAnchester PAScal® Study report 2. 
    MMK Muqit, Marcellino GR, Gray JCB, McLauchlan R, DB. Henson, LB Young, N Patton, SJ Charles, GS Turner, Stanga PE.
    Br J Ophthalmol. 2010 Nov;94(11):1493-8.
    Epub 2010 Jun 16. Review
  29. BRC Support Barely-Visible 10ms Pascal® Laser Photocoagulation for Diabetic Macular Edema: Observations of Clinical Effect and Burn Localisation. 
    MMK. Muqit, JCB Gray, GR Marcellino, DB. Henson, LB Young, N Patton, SJ Charles, GS Turner, PE Stanga.
    Am J Ophthalmol 2010; 149(6): 979-986.e2.
  30. BRC Support Single-session versus Multiple-session Pascal Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: MAnchester PAScal Study. 
    MMK. Muqit, DB. Henson, LB Young, N Patton, SJ Charles, GS Turner, GR Marcellino, PE Stanga.
    Arch Ophthalmol 2010; 128(5): 525-33.
  31. BRC Support Exudative retinal detachment following photodynamic therapy for retinal capillary hemangioma. 
    Wong YM, Jalil A, Mathews J, Stanga PE.
    Can J Ophthalmol. 2010 Jun;45(3):299-300.
  32. BRC Support In vivo laser-tissue interactions and healing responses from 20- versus 100-millisecond pulse Pascal photocoagulation burns. 
    MMK Muqit, JC Gray, GR Marcellino, LB Young, N Patton, SJ Charles, GS Turner, AD Dick, PE Stanga.
    Arch Ophthalmol 2010;128(4):448-55.
  1. BRC Support Comment and reply on: Structural changes of the retina after laser photocoagulation in spectral domain optical coherence tomography. 
    PE Stanga, MMK Muqit, GR Marcellino.
    Curr Eye Res. 2010 Mar;35(3):255-6; author reply 257-8.
  2. BRC Support Retinal Laser Photocoagulation, Anaesthesia and Pain Responses. 
    PE Stanga and MMK Muqit.
    Eye (Lond). 2010 Aug;24(8):1415-6; author reply 1416-7.
    Epub 2010 Mar 26.
  3. BRC Support Study of clinical applications and safety for Pascal® laser photocoagulation in retinal vascular disorders. 
    Muqit MMK, C Sanghvi, Marcellino GR, LB Young, SJ Charles, PE Stanga.
    Acta Ophthalmol. 2010 Feb 16.
    [Epub ahead of print]
  4. Effects of Conventional Argon Panretinal Laser Photocoagulation on Retinal Nerve Fibre Layer and Driving Visual Fields in Diabetic Retinopathy. 
    MMK Muqit, L Wakely, PE Stanga, DB Henson, FD Ghanchi.
    Eye (Lond). 2010 Jul;24(7):1136-42.
    Epub 2009 Dec 18.
  5. Verteporfin Photodynamic Therapy Cohort Study Group. Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes. 
    Harding SP, Tomlin K, Reeves BC, Langham J, Walker J, Carpenter J, Grieve R, Patton WP, Muldrew KA, Peto T, Chakravarthy U;
    Ophthalmology. 2009 Dec;116(12):e1-8.
  6. Presumed early-onset sarcoidosis: a case of devastating ocular inflammation in an infant. 
    Bhojwani R, Houtman AC, Stanga P, Bonshek R, Lloyd IC, Baildam E, Biswas S.
    J Pediatr Ophthalmol Strabismus. 2009 Jul-Aug;46(4):245-8. doi: 10.3928/01913913-20090706-15.
    Epub 2009 Mar 20.
  7. Choroidal nonperfusion with significant subretinal exudation after PDT of predominantly classic CNV: an OCT and FFA study. 
    Jalil A, Mercieca K, Chaudhry NL, Stanga PE.
    Eur J Ophthalmol. 2009 May-Jun;19(3):490-3.
  8. Fundus Autofluorescence and Fourier-Domain Optical Coherence Tomography Imaging of 10 and 20 millisecond Pascal® Retinal PhotocoagulationTreatment. 
    Muqit MMK, Gray JCB, Marcellino G, Henson D, Young L, Charles SJ, Turner GS, Stanga PE.
    Br J Ophthalmol. 2009 Apr;93(4):518-25.
    Epub 2008 Dec 15.
  9. Successful surgical treatment of optic disc pit maculopathy. 
    Ziahosseini K, Sanghvi C, Muzaffar W, Stanga PE.
    Eye (Lond). 2009 Jun;23(6):1477-9.
    Epub 2008 Jul 25.
  10. Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures. 
    Sanghvi C, McLauchlan R, Delgado C, Young L, Charles SJ, Marcellino G, Stanga PE.
    Br J Ophthalmol. 2008 Aug;92(8):1061-4.
    Epub 2008 Jun 27.
  11. Retinal Pigment Epithelial Tear Following Intravitreal Injection of Bevacizumab (Avastin ®): Optical Coherence Tomography and Fluorescein Angiographic Findings. 
    JP Mathews, Jalil A, JP, MJ Lavin, Stanga PE.
    Submitted for publication and currently being peer-reviewed. Eye. 2007;21(7):1004-5.
    Epub 2007 May 4.
  12. Optical Coherence Tomography Analysis of Bilateral End-stage Choroidal Neovascularisation where one eye is treated with Photodynamic Therapy. 
    Sahni J, Stanga P, Wong D, Lenfestey P, Kent D, Harding S.
    Clinical and Experimental Ophthalmology. Clin Experiment Ophthalmol. 2007;35(1):13-7
  13. X-linked retinoschisis: an update. 
    Sikkink SK, Biswas S, Parry NR, Stanga PE, Trump D.
    J Med Genet. 2007 44(4):225-32.
    Epub 2006 Dec 15. Review.
  14. Solar retinopathy in a patient with bipolar affective disorder. 
    Devadason DS, Mahmood S, Stanga PE, Bishop PN.
    Br J Ophthalmol. 2006 Feb;90(2):247.
  15. Pre-eclampsia resulting in central retinal vein occlusion. 
    Rahman I, Saleemi G, Semple D, Stanga P.
    Eye. 2005 Aug 5.
  16. Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study. 
    Sahni J, Stanga P, Wong D, Harding S.
    Br J Ophthalmol. 2005;89(3):316-20.
  17. Case Selection in Macular Relocation Surgery for Age-related Macular Degeneration. 
    Wong D, Stanga P, Briggs MC, Lenfesty P, Lancaster E, Li K, Lim KS, Groenewald CP.
    Br J Ophthalmol. 2004;88(2):186-90.
  18. Macular Relocation after Photodynamic Therapy for Recurrent CNV: Visual Results and Histopathological Findings. 
    Stanga PE, Hiscott P, Li K, Wong D.
    Br J Ophthalmol. 2003;87(8):975-6.
  19. Isolated foveal retinoschisis as a cause of visual loss in young females. 
    Kabanarou SA, Holder GE, Bird AC, Webster AR, Stanga PE, Vickers S, Harney BA.
    Br J Ophthalmol 2003;87(6):801-3.
  20. Measurement of Cyclotorsion in a Patient Following Macular Translocation Surgery Using a Modified version of the Watzke-Allen-Test. 
    T. Stappler, P. E. Stanga, C. Groenewald, I. El Bably, D. Wong.
    Retina 2003;23(2):250-2.
  21. Indocyanine Green Angiography in Ocular Diseases; Indications and Interpretation – An Evidence-based Update (Review article). 
    P. Stanga, J. Lim, A. M. P. Hamilton.
    Ophthalmology 2003;110(1):15-21; quiz 22-3.
  22. Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. 
    K. Li, D. Wong, P. Hiscott, P. E. Stanga, C. Groenewald, J. McGalliard.
    Br J Ophthalmol 2003;87(2):216-9
  23. Age-related antioxidant capacity of the vitreous and its possible relationship with simultaneous changes in photoreceptors, retinal pigment epithelium and Bruchs’ membrane in human donors’ eyes. 
    A. Berra, S. Ferreira, P. Stanga, S. Llesuy.
    Arch Gerontol Geriatr 2002;34(3):371-7
  24. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. 
    P. E. Stanga, A. Kychenthal, F W. Fitzke, A. S. Halfyard, R. Chan, A. C. Bird, G. W. Aylward.
    Ophthalmol 2002;109(8):1492-8.
  25. Bird Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results. 
    P. Stanga, S. Downes, R. Ahuja, N. Chong, R. Antcliff, A. Reck, A.
    Int Ophthalmol 2001;23(4-6):321-5.
  26. Functional assessment of the native retinal pigment epithelium after the surgical excision of subfoveal choroidal neovascular membranes type II: preliminary results. 
    P. Stanga, A. Kychenthal, F. Fitzke, A. Halfyard, R. Chan, R. Asaria, A. Bird, W. Aylward.
    Int Ophthalmol 2001;23(4-6):309-16.
  27. Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results. 
    P. Stanga, A. Kychenthal, F. Fitzke, A. Halfyard, R. Chan, A. Bird, W. Aylward.
    Int Ophthalmol 2001;23(4-6):297-307.
  28. Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results. 
    P. Stanga, A. Bird.
    Int Ophthalmol 2001;23(4-6):191-7.
  29. Polypoidal choroidal vasculopathy and central serous chorioretinopathy. 
    R. M. Ahuja, S. M. Downes, P. Stanga, A. H. Koh, J. R. Vingerling, A. C. Bird.
    Ophthalmol 2001; 108(6):1009-10.
  30. Optical Coherence Tomography (OCT) and Electrophysiology in X-Linked Juvenile Retinoschisis Associated with a Novel Mutation in the XLRS1 Gene. 
    P. Stanga, N. H. V. Chong, A. Reck, A. J. Hardcastle, G. E. Holder.
    Retina 2001; 21(1):78-80.
  31. Polypoidal choroidopathy in patients with hemorrhagic and exudative pigment epithelial detachments Degeneration 
    R. M. Ahuja, P. Stanga, J. R. Vingerling, A. Reck, A.C. Bird.
    Br J Opthalmol; 2000; 84: 0-5.
  32. Imaging of a traumatic macular hole with spontaneous closure. 
    D. N. Parmar, P. Stanga, A. C. Reck, J. R. Vingerling, P. Sullivan.
    Retina 1999; 19(5): 470-472.
  33. Ocular manifestations of diabetes mellitus. 
    P. Stanga, S. R. Boyd, A M. P. Hamilton.
    Curr Opin Ophthalmol 1999; 10:483-489.
  34. Micropulse laser in the treatment of diabetic macular edema. 
    P. Stanga, A. C. Reck, A. M. P. Hamilton.
    Sem Ophthalmol 1999; 14(4): 210-13.
  35. A Retained Catheter for Retrobulbar Administration of Interferon for Age-Related Macular Degeneration. 
    H. Lincoff, I. Kreissig, F. Gelisken, P. Stanga
    Wiedemann P, Kohen L (eds.): Macular and Retinal Diseases. Dev Ophthalmol. Basel, Karger, 29: 69–77, 1997.
  36. Free paper discussion: Fotosensibilización del melanoma de coroides con indocianina verde y diodo de 810 nm por A.
    P. Stanga.
    Alezzandrini (h) et al. Archiv de Oftalmol Bs As 1.996; 71: 129.
  37. Estatus Oxidativo y Degeneración Macular Asociada a la Edad – Anuario 1996 de la Fundación Dr. J. Roberto Villavicencio (Rosario).
    P. Stanga, E. Piatti, H. Nano, J. Bafalluy, C Fraga
    1996; 4: 91-4. Reg. Nac. De Prop. Int. Nº: 16731.
  38. Choroidal Concentration of Interferon After Retrobulbar Injection (Report) 
    H. Lincoff, P. Stanga, A. Movshovich, A. Palleroni, B. Madjarov, R. Rivera, R. Silverman
    Invest Ophthalmol Vis Sci 1996; 37 (13): 2768-71.
  39. Free Radicals and Ophthalmology: Macular Degeneration.
    P. Stanga.
    Antioxidants and Life Quality 1995; 2 (7):31-2. ISSN 0328-090X.
  40. “Retinal Detachment – review”.
    H. Nano – G. Amado – A. Bastien – O. Roux – P. Stanga
    Archiv de Oftalmol Bs As 1995; 70: 77-107
  41. Refractive postoperative evaluation after the Intraocular lens implant in 67 patients.
    P. Stanga – J. Bafalluy – H. D. Nano.
    Archiv de Oftalmol Bs As 1991; 66:99-101

Other publications:

New Laser Technology and Techniques for Treating DME and PDR Paulo E. Stanga; Maria Gil Martinez; Salvador Pastor-Idoate Supplement to Retina Today. January 2014.

Subthreshold Retinal Treatment With Yellow 577-nm PASCAL Laser. Paulo E. Stanga Retina Today. January 2013.


Regulations for the Diagnosis and Therapy of Eye Diseases – ISBN: 950-16-6901-7, 1st. Ed., 1995